E-LIB Suche - Ergebnisse für: Fenaux, Pierre

1

Guadecitabine vs TC in relapsed/refractory AML after intens..:

Roboz, Gail J. ; Sanz, Guillermo ; Griffiths, Elizabeth A....
Blood Advances. 8 (2024) 8 - p. 2020-2029 , 2024

Link: https://doi.org/10.1182/..

2

Sabatolimab plus hypomethylating agents in previously untre..:

Zeidan, Amer M ; Ando, Kiyoshi ; Rauzy, Odile...
The Lancet Haematology. 11 (2024) 1 - p. e38-e50 , 2024

Link: https://doi.org/10.1016/..

3

Toward a more patient‐centered drug development process in ..:

Efficace, Fabio ; Buckstein, Rena ; Abel, Gregory A....
HemaSphere. 8 (2024) 5 - p. , 2024

Link: https://doi.org/10.1002/..

4

Cutaneous clonal mature plasmacytoid dendritic cell dermato..:

Mahévas, Thibault ; Osio, Amélie ; Larcher, Lise...
Blood Advances. , 2024

Link: https://doi.org/10.1182/..

5

Niclosamide combined to Azacitidine to target TP53-mutated ..:

Maslah, Nabih ; Rety, Salome ; Bonnamy, Melina...
Leukemia. , 2024

Link: https://doi.org/10.1038/..

6

Germline CHEK2 mutations in patients with myeloid neoplasms:

Freiman, Lucie ; Larcher, Lise ; Tueur, Giulia...
Leukemia. 38 (2024) 4 - p. 908-911 , 2024

Link: https://doi.org/10.1038/..

7

Accelerated DNA replication fork speed due to loss of R-loo..:

Rombaut, David ; Lefèvre, Carine ; Rached, Tony...
Nature Communications. 15 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..

8

Clinical impact of genetic alterations including germline D..:

Sébert, Marie ; Freiman, Lucie ; Chaffaut, Cendrine...
Leukemia. 38 (2024) 4 - p. 918-922 , 2024

Link: https://doi.org/10.1038/..

9

Venetoclax and Cobimetinib in Relapsed/Refractory AML: A Ph..:

Konopleva, Marina Y. ; Dail, Monique ; Daver, Naval G....
Clinical Lymphoma Myeloma and Leukemia. 24 (2024) 6 - p. 364-374 , 2024

Link: https://doi.org/10.1016/..

10

Molecular alterations monitoring in myelodysplastic patient..:

Robin, Marie ; Nibourel, Olivier ; Tournaire, Martin...
Bone Marrow Transplantation. , 2024

Link: https://doi.org/10.1038/..

11

Imetelstat in patients with lower-risk myelodysplastic synd..:

Platzbecker, Uwe ; Santini, Valeria ; Fenaux, Pierre...
The Lancet. 403 (2024) 10423 - p. 249-260 , 2024

Link: https://doi.org/10.1016/..

12

Olutasidenib in post-venetoclax patients with mutant isocit..:

Cortes, Jorge ; Jonas, Brian A. ; Schiller, Gary...
Leukemia & Lymphoma. , 2024

Link: https://doi.org/10.1080/..

13

What role for somatic mutations in systemic inflammatory an..:

Zhao, Lin-Pierre ; Sébert, Marie ; Mékinian, Arsène...
Leukemia. , 2023

Link: https://doi.org/10.1038/..

14

S173: RETROSPECTIVE STUDY OF LENALIDOMIDE DISCONTINUATION I..:

Crisà, Elena ; Díez Campelo, María ; Germing, Ulrich...
HemaSphere. 7 (2023) S3 - p. e93218cc , 2023

Link: https://doi.org/10.1097/..

15

Myelodysplastic Syndrome associated TET2 mutations affect N..:

Boy, Maxime ; Bisio, Valeria ; Zhao, Lin-Pierre...
Nature Communications. 14 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..